Jump to content

Harrison Stafford

Legacy Members
  • Posts

    2912
  • Joined

  • Last visited

Everything posted by Harrison Stafford

  1. Dallas is terrible at football.
  2. They might want to double Hunter…..and everybody else on the D line.
  3. That was a horrible call.
  4. There’s no strict limit on how many times you can use the word “nefarious”.
  5. Governor Abbott, PUCT Release Texas Advanced Nuclear Reactor Working Group Report November 18, 2024 | Austin, Texas | Press Release Governor Greg Abbott and the Public Utility Commission of Texas (PUCT) today announced the release of the Texas Advanced Nuclear Reactor Working Group’s final report on Texas’ plan to build a world-leading advanced nuclear power industry to enhance electric reliability and energy security, promote economic development, and unleash new opportunities for the growing Texas workforce. “Texas is the energy capital of the world, and we are ready to be No. 1 in advanced nuclear power,” said Governor Abbott. “By utilizing advanced nuclear energy, Texas will enhance the reliability of the state grid and provide affordable, dispatchable power to Texans across the state. I thank Public Utility Commissioner Jimmy Glotfelty and the members of the Texas Advanced Nuclear Reactor Working Group for working tirelessly to put Texas on the path to be the global leader in advanced nuclear power. As we build an advanced nuclear industry in our great state, we will ensure Texas remains a leader in energy and strengthen the Texas grid to meet the demands of our growing state.” “Texas has long been the energy capital of the world, and today we have an incredible opportunity to build a world-leading advanced nuclear industry that will deliver safe, reliable power for generations to come,” PUCT Commissioner Jimmy Glotfelty said. “I want to thank the Governor for his direction on this important issue and the many people who dedicated their time and expertise to this work. The economic and policy recommendations we’ve outlined will inspire swift action and help Texas become the leader in advanced nuclear energy.” In August 2023, Governor Abbott directed the PUCT to form a working group to study and plan for the use of advanced nuclear reactors in Texas. Over the past year, the working group developed key recommendations and strategies to position Texas as No. 1 in the advanced nuclear industry. ——————————————————————————————————————————————————————————————————————————————— UUUU +.65 to $7.29. Looking hard at additional uranium exposure with UEC (+.86 to $8.28) which is headquartered in Corpus Christi.
  6. The man’s been married seven times. Getting married is easy. Staying married is much harder.
  7. Somebody gimme a cheeseburger!
  8. Paul Rodgers of Free & Bad Company plus Jimmy Page of Led Zeppelin. “Alex, I’ll take uranium for $200.”
  9. At least, they got the town right. I saw Jethro Tull in Houston in the early 70’s and Ian Anderson comes on stage and says, “Hello to all you fuckers in Cleveland”.
  10. You hit us in the fucking face and we hit you right back in the fucking face.
  11. I think you’re on to something. Let’s do this.
  12. How ‘bout them Dawgz!
  13. Last Friday premarket, Energy Fuels (UUUU) reported a miss with Q3 earnings and the stock dropped from $6.05 to a low Monday of $5.36. UUUU has recovered currently trading at $6.28. UUUU continues to actively expand their facilities increasing capacity to produce more uranium, rare earths, and medical Isotopes in 2025 while sitting on supplies of finished uranium and vanadium waiting for uranium prices to go up. They have plenty of cash ($1.21/sh, $234 million) and no debt. Yesterday, EOSE reported a miss with Q3 earnings due to temporary supply chain issues and the stock dropped from $3.20 to $2.26. EOSE has recovered some currently trading at $2.85 (blessed are the dip buyers). No one expected them to be profitable yet. This is a 2025 story.
  14. I was envious of the man for marrying Peggy Lipton of the Mod Squad.
  15. I hated this World Series matchup. My only ask was that whoever loses does lose it in the most brutal way possible. That will suffice.
  16. Agreed, but you’d have to draft any number of aggy stiffs before stumbling upon an outlier like Evans.
  17. Never. Draft. Aggy. NEVER.
  18. My brother and I will be in Vegas for the F1 Grand Prix in the latter part of November staying at the V/P. Our rooms are comped and, for the first time, we have a host at these properties. She gave us both room upgrades (I asked for them plus a bunch of other comps we didn’t get). Should I give her a tip during our stay?
  19. The fact that earlier this year PSU’s Board of Trustees even considered renaming their football stadium to honor Joe Paterno the enabler tells you just how fucked up they are. That football program should have been given the death penalty.
  20. The only way I’d sell is if we got the mother of all short squeezes. Then, I’d sell it all as the market makers will run it all the way back once the shorts have been forced out. Then, I’d buy it all back.
  21. IBRX has busted through $7. Up $3.26 to $7.47. Koo koo kachoo.
  22. IBRX +$1.61 to $5.82. Still a third of the float sold short.
  23. Yesterday was almost too much for me. Good thing my nurse is on call.
  24. “EF Hutton analyst Jason Kolbert initiated coverage of ImmunityBio stock with a Buy rating and a $30 price target on Wednesday. That implies a startling 767% upside to its current share price of $3.46. ImmunityBio is a San Diego, Calif.-based late-stage clinical biotech poised to revolutionize cancer immunotherapy, according to Kolbert. The company’s lead product Anktiva works by activating the body’s natural immune system to eliminate tumor cells and provide long-term immune memory against cancer. It was approved by the Food and Drug Administration in April this year for adult patients with a cancer unresponsive to the most common intravesical immunotherapy (BCG), non-muscle invasive bladder cancer. Anktiva’s ability to convert cold tumors into hot ones—making them more responsive to immune attack—is particularly effective as cold tumors typically evade detection, Kolbert noted. This can potentially improve outcomes in various cancers, including those traditionally treated with checkpoint inhibitors, such as melanoma, lung, ovarian, and colorectal cancers, by making them more vulnerable to an immune system attack, he added. The small-cap company has a market value of $2.8 billion, and has yet to report a quarterly profit since its listing on Nasdaq in March 2021, which isn’t uncommon for start-up biotechs. The stock rose 8.7% to $3.76 Thursday. At Wednesday’s close, the stock was down 31% for the year”. ^^^^^^^^^^^^^^^^^^^^^ An article in today’s Barron’s. IBRX +.68 to $4.14. Today’s price will be a distant memory when the stock’s at $100/share.
×
×
  • Create New...